Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Alopecia areata totalis and universalis: a multicenter review of 132 patients in Spain

Journal article
Authors S. Vano-Galvan
P. Fernandez-Crehuet
R. Grimalt
M. J. Garcia-Hernandez
R. Rodrigues-Barata
S. Arias-Santiago
A. Molina-Ruiz
E. Garcia-Lora
J. Dominguez-Cruz
A. Brugues
J. Ferrando
C. Serrano-Falcon
S. Serrano
John Paoli
F. Camacho
Published in Journal of the European Academy of Dermatology and Venereology
Volume 31
Issue 3
Pages 550-556
ISSN 0926-9959
Publication year 2017
Published at Institute of Clinical Sciences, Section for Oncology, Radiation Physics, Radiology and Urology, Department of Dermatology and Venereology
Pages 550-556
Language en
Links doi.org/10.1111/jdv.13959
Keywords pulse methylprednisolone therapy, term-follow-up, corticosteroid-therapy, systemic corticosteroids, oral corticosteroids, efficacy, update, combination, experience, methotrexate, Dermatology
Subject categories Dermatology and Venereal Diseases

Abstract

BackgroundAlopecia areata totalis (AAT) and universalis (AAU) pose a therapeutic challenge. ObjectiveTo describe the clinical and epidemiological features, therapeutic response and prognostic factors in a large series of patients diagnosed with AAT and AAU. MethodsThis retrospective multicenter study included patients diagnosed with AAT/AAU with a minimum follow-up of 12 months. Response was assessed based on the regrowth of scalp hair. ResultsIn all, 132 patients (92 women and 40 men) - 80 (61%) diagnosed with AAU and 52 (39%) diagnosed with AAT - were included. The median time between the presentation of alopecia areata (AA) and the development of extensive AA was 1 year and it was less than 4 years in 121 patients (91%). There was an initial response to treatment in 64% of patients, although only 14% presented a persistent response. Adverse side effects from the medications used were detected in 33% of patients. The prognostic factors associated with poor response were the presence of AAU and a positive family history of AA. ConclusionsTreatment of AAT and AAU is challenging. Although an initial regrowth may be achieved, the duration of response is usually short. There were no significant differences on the effectiveness or duration of response between the various systemic therapies.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?